Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors
- PMID: 9171880
- DOI: 10.1021/jm970081i
Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors
Abstract
Re-examination of the design of the cyclic urea class of HIV protease (HIVPR) inhibitors suggests a general approach to designing novel nonpeptide cyclic HIVPR inhibitors. This process involves the inversion of the stereochemical centers of the core transition-state isostere of the linear HIVPR inhibitors and cyclization of the resulting core using an appropriate cyclizing reagent. As an example, this process is applied to the diamino alcohol class of HIVPR inhibitors to give tetrahydropyrimidinones. Conformational analysis of the tetrahydropyrimidinones and modeling of its interaction with the active site of HIVPR suggested modifications which led to very potent inhibitors of HIVPR (24 with a Ki = 0.018 nM). The X-ray crystallographic structure of the complex of 24 with HIVPR confirms the analysis and modeling predictions. The example reported in this study and other examples that are cited indicate that this process may be generally applicable to other linear inhibitors.
Similar articles
-
Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease.Biochemistry. 1999 Jun 22;38(25):7978-88. doi: 10.1021/bi990174x. Biochemistry. 1999. PMID: 10387041
-
Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality.Bioorg Med Chem Lett. 2007 Oct 15;17(20):5614-9. doi: 10.1016/j.bmcl.2007.07.095. Epub 2007 Aug 23. Bioorg Med Chem Lett. 2007. PMID: 17822899
-
Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors.J Med Chem. 1999 Jan 14;42(1):135-52. doi: 10.1021/jm9803626. J Med Chem. 1999. PMID: 9888839
-
Nonpeptidic potent HIV-1 protease inhibitors.Drug Des Discov. 1996 Apr;13(3-4):15-28. Drug Des Discov. 1996. PMID: 8874041 Review.
-
De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.Pharm Biotechnol. 1998;11:257-84. doi: 10.1007/0-306-47384-4_12. Pharm Biotechnol. 1998. PMID: 9760684 Review. No abstract available.
Cited by
-
Catalytic, Enantioselective Sulfenofunctionalization of Alkenes: Development and Recent Advances.Angew Chem Int Ed Engl. 2020 Nov 2;59(45):19796-19819. doi: 10.1002/anie.202005920. Epub 2020 Aug 18. Angew Chem Int Ed Engl. 2020. PMID: 32452077 Free PMC article. Review.
-
Synthesis and crystal structure of 2-(2-hy-droxy-phen-yl)-1,3-bis-(4-meth-oxy-benz-yl)-1,3-diazinan-5-ol.Acta Crystallogr E Crystallogr Commun. 2022 Jun 28;78(Pt 7):742-745. doi: 10.1107/S2056989022006508. eCollection 2022 Jul 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 35855366 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Research Materials